Bal Pharma

quarterly
yearly
ParticularsSep '24Dec '24Mar '25Jun '25Sep '25
Revenue73.4973.6682.9666.5975.14
Expenses72.1373.0980.3766.3874.43
EBITDA7.498.278.726.786.85
EBIT5.015.586.544.264.58
Profit Before Tax1.360.572.590.210.72
Net Profit1.040.525.420.210.72
Financial Ratios
Operating Profit Margin10.16%11.29%10.65%10.29%9.25%
Net Profit Margin1.41%0.66%6.63%0.30%0.96%
Earning Per Share (Diluted)0.650.333.400.130.45
Dividends Per Share0.000.000.000.000.00